{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T18:46:30Z","timestamp":1791744390438,"version":"4.3.4"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-026-03343-y","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T17:29:03Z","timestamp":1781803743000},"page":"2007-2028","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Thromboinflammatory biomarkers and thrombotic risk in virologic failure and drug-resistant HIV: Emerging roles of d-dimer, fibrinogen, and coagulation dysregulation"],"prefix":"10.1007","volume":"59","author":[{"given":"Emmanuel Ifeanyi","family":"Obeagu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5585-1134","authenticated-orcid":false,"given":"Michael Ben","family":"Okon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"issue":"9","key":"3343_CR1","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00705-025-06381-8","volume":"170","author":"K \u0141upina","year":"2025","unstructured":"\u0141upina K, Nowak K, Lorek D, Nowak A, Romac A, G\u0142owacka E, Janczura J (2025) Pharmacological advances in HIV treatment: from ART to long-acting injectable therapies. Arch Virol 170(9):195. https:\/\/doi.org\/10.1007\/s00705-025-06381-8","journal-title":"Arch Virol"},{"key":"3343_CR2","doi-asserted-by":"publisher","first-page":"1133407","DOI":"10.3389\/fmicb.2023.1133407","volume":"14","author":"A Temereanca","year":"2023","unstructured":"Temereanca A, Ruta S (2023) Strategies to overcome HIV drug resistance-current and future perspectives. Front Microbiol 14:1133407. https:\/\/doi.org\/10.3389\/fmicb.2023.1133407","journal-title":"Front Microbiol"},{"key":"3343_CR3","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.coviro.2021.09.009","volume":"51","author":"L Blassel","year":"2021","unstructured":"Blassel L, Zhukova A, Villabona-Arenas CJ, Atkins KE, Hu\u00e9 S, Gascuel O (2021) Drug resistance mutations in HIV: new bioinformatics approaches and challenges. Curr Opin Virol 51:56\u201364","journal-title":"Curr Opin Virol"},{"issue":"5","key":"3343_CR4","doi-asserted-by":"publisher","first-page":"135965352312011","DOI":"10.1177\/13596535231201162","volume":"28","author":"A Carr","year":"2023","unstructured":"Carr A, Mackie NE, Paredes R, Ruxrungtham K (2023) HIV drug resistance in the era of contemporary antiretroviral therapy: a clinical perspective. Antivir Ther 28(5):13596535231201162","journal-title":"Antivir Ther"},{"issue":"11","key":"3343_CR5","doi-asserted-by":"publisher","first-page":"e150","DOI":"10.1161\/CIRCRESAHA.124.323979","volume":"134","author":"P Prakash","year":"2024","unstructured":"Prakash P, Swami Vetha BS, Chakraborty R, Wenegieme TY, Masenga SK, Muthian G, Balasubramaniam M, Wanjalla CN, Hinton AO Jr, Kirabo A, Williams CR (2024) HIV-associated hypertension: risks, mechanisms, and knowledge gaps. Circul Res 134(11):e150\u2013e175","journal-title":"Circul Res"},{"issue":"1","key":"3343_CR6","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3892\/br.2025.2000","volume":"23","author":"G Dryllis","year":"2025","unstructured":"Dryllis G, Vasilopoulou M, Politou M, Gerogkiokas A, Pittaras T, Zoumpourlis V, Spandidos DA, Gialeraki A (2025) Thrombotic and cardiovascular events in HIV infection (Review). Biomed Rep 23(1):122. https:\/\/doi.org\/10.3892\/br.2025.2000","journal-title":"Biomed Rep"},{"issue":"8","key":"3343_CR7","doi-asserted-by":"publisher","first-page":"5070","DOI":"10.1097\/MS9.0000000000003533","volume":"87","author":"EI Obeagu","year":"2025","unstructured":"Obeagu EI (2025) Thrombosis risk in sickle cell disease with HIV co-infection: unraveling the complex interactions and clinical implications - a narrative review. Ann Med Surg (Lond) 87(8):5070\u20135076. https:\/\/doi.org\/10.1097\/MS9.0000000000003533","journal-title":"Ann Med Surg (Lond)"},{"issue":"18","key":"3343_CR8","doi-asserted-by":"publisher","first-page":"14179","DOI":"10.3390\/ijms241814179","volume":"24","author":"CL Hvas","year":"2023","unstructured":"Hvas CL, Larsen JB (2023) The Fibrinolytic System and Its Measurement: History, Current Uses and Future Directions for Diagnosis and Treatment. Int J Mol Sci 24(18):14179. https:\/\/doi.org\/10.3390\/ijms241814179","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3343_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.blre.2014.09.003","volume":"29","author":"JC Chapin","year":"2015","unstructured":"Chapin JC, Hajjar KA (2015) Fibrinolysis and the control of blood coagulation. Blood Rev 29(1):17\u201324. https:\/\/doi.org\/10.1016\/j.blre.2014.09.003","journal-title":"Blood Rev"},{"issue":"3","key":"3343_CR10","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1161\/ATVBAHA.117.308564","volume":"37","author":"S Kattula","year":"2017","unstructured":"Kattula S, Byrnes JR, Wolberg AS (2017) Fibrinogen and Fibrin in Hemostasis and Thrombosis. Arterioscler Thromb Vasc Biol 37(3):e13\u2013e21. https:\/\/doi.org\/10.1161\/ATVBAHA.117.308564","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"3343_CR11","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3390\/antiox14040390","volume":"14","author":"F Nencini","year":"2025","unstructured":"Nencini F, Giurranna E, Borghi S, Taddei N, Fiorillo C, Becatti M (2025) Fibrinogen Oxidation and Thrombosis: Shaping Structure and Function. Antioxidants 14(4):390. https:\/\/doi.org\/10.3390\/antiox14040390","journal-title":"Antioxidants"},{"issue":"3","key":"3343_CR12","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/COH.0b013e32835f9788","volume":"8","author":"H Hatano","year":"2013","unstructured":"Hatano H (2013) Immune activation and HIV persistence: considerations for novel therapeutic interventions. Curr Opin HIV AIDS 8(3):211\u2013216. https:\/\/doi.org\/10.1097\/COH.0b013e32835f9788. PMID: 23454864; PMCID: PMC4041488","journal-title":"Curr Opin HIV AIDS"},{"key":"3343_CR13","doi-asserted-by":"publisher","first-page":"17197","DOI":"10.2147\/JIR.S472896","volume":"31","author":"H Mokoena","year":"2025","unstructured":"Mokoena H, Hanser S, Mabhida SE, Choshi J, Sekgala MD, Nkambule BB, Mchiza ZJ, Ndwandwe DE, Kengne AP, Dludla PV (2025) The Pathological Link Between Elevated Markers of Inflammation, Endothelial Activation, and Cardiovascular Diseases in People Living with HIV on Combination Antiretroviral Therapy: A Systematic Review. J Inflamm Res 31:17197\u201317210","journal-title":"J Inflamm Res"},{"issue":"6","key":"3343_CR14","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1111\/hiv.70017","volume":"26","author":"M Saumoy","year":"2025","unstructured":"Saumoy M, Fernandez A, Tiraboschi J, Pe\u00f1afiel J, S\u00e1nchez-Quesada JL, Vega J, Garc\u00eda B, Soriano I, Podzamczer D, Imaz A (2025) Biomarkers of inflammation and coagulation predict non\u2010AIDS\u2010defining events in a prospective cohort of virologically suppressed people living with HIV. HIV Med 26(6):849\u2013857","journal-title":"HIV Med"},{"key":"3343_CR15","doi-asserted-by":"crossref","unstructured":"Graham SM, Nance RM, Chen J, Le J, Chung DW, Wurfel MM, Tirschwell DL, Zunt JR, Marra CM, Ho EL, Huffer A (2021) Elevated plasma von Willebrand factor levels are associated with subsequent ischemic stroke in persons with treated HIV infection. InOpen Forum Infectious Diseases. ;8(11): ofab521). US: Oxford University Press","DOI":"10.1093\/ofid\/ofab521"},{"issue":"6","key":"3343_CR16","doi-asserted-by":"publisher","first-page":"839","DOI":"10.3390\/v17060839","volume":"17","author":"E Teer","year":"2025","unstructured":"Teer E, Mukonowenzou NC, Essop MF (2025) HIV, Inflammation, and Immunometabolism: A Model of the Inflammatory Theory of Disease. Viruses 17(6):839. https:\/\/doi.org\/10.3390\/v17060839. PMID: 40573430; PMCID: PMC12197572","journal-title":"Viruses"},{"key":"3343_CR17","doi-asserted-by":"crossref","unstructured":"Marietta M, Coluccio V, Cordella S, Luppi M Impact of viral infections on the hemostatic system. In Seminars in thrombosis and hemostasis 2025 May 27. Thieme Medical Publishers, Inc.","DOI":"10.1055\/a-2601-9302"},{"key":"3343_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.htct.2023.05.008","volume":"46","author":"AC Nardi","year":"2024","unstructured":"Nardi AC, Coy-Cangu\u00e7u A, Saito A, Florio MF, Marti G, Degasperi GR, Orsi FA (2024) Immunothrombosis and its underlying biological mechanisms. Hematol Transfus Cell Therapy 46:49\u201357","journal-title":"Hematol Transfus Cell Therapy"},{"key":"3343_CR19","doi-asserted-by":"crossref","unstructured":"Larsen JB, Hvas AM (2021) Thrombin: a pivotal player in hemostasis and beyond. InSeminars in thrombosis and hemostasis. ;47(7):759\u2013774). Thieme Medical Publishers, Inc","DOI":"10.1055\/s-0041-1727116"},{"issue":"8","key":"3343_CR20","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1097\/QAD.0b013e32835ecb8b","volume":"27","author":"R Rajasuriar","year":"2013","unstructured":"Rajasuriar R, Khoury G, Kamarulzaman A, French MA, Cameron PU, Lewin SR (2013) Persistent immune activation in chronic HIV infection: do any interventions work? AIDS 27(8):1199\u20131208. https:\/\/doi.org\/10.1097\/QAD.0b013e32835ecb8b","journal-title":"AIDS"},{"key":"3343_CR21","doi-asserted-by":"crossref","unstructured":"Signorelli SS, Oliveri Conti G, Fiore M, Cangiano F, Zuccarello P, Gaudio A, Ferrante M (2020) Platelet-Derived Microparticles (MPs) and Thrombin Generation Velocity in Deep Vein Thrombosis (DVT): Results of a Case\u2013Control Study. Vascular health and risk management, pp 489\u2013495","DOI":"10.2147\/VHRM.S236286"},{"issue":"11","key":"3343_CR22","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1161\/CIRCRESAHA.124.323891","volume":"134","author":"LM Obare","year":"2024","unstructured":"Obare LM, Temu T, Mallal SA, Wanjalla CN (2024) Inflammation in HIV and Its Impact on Atherosclerotic Cardiovascular Disease. Circ Res 134(11):1515\u20131545. https:\/\/doi.org\/10.1161\/CIRCRESAHA.124.323891","journal-title":"Circ Res"},{"key":"3343_CR23","doi-asserted-by":"crossref","unstructured":"Jackson BS, Pretorius E (2019) Pathological clotting and deep vein thrombosis in patients with HIV. In Seminars in thrombosis and hemostasis. ;45(2):132\u2013140. Thieme Medical Publishers","DOI":"10.1055\/s-0038-1676374"},{"issue":"5","key":"3343_CR24","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.thromres.2013.08.016","volume":"132","author":"JV Baker","year":"2013","unstructured":"Baker JV (2013) Chronic HIV disease and activation of the coagulation system. Thromb Res 132(5):495\u2013499. https:\/\/doi.org\/10.1016\/j.thromres.2013.08.016","journal-title":"Thromb Res"},{"key":"3343_CR25","doi-asserted-by":"publisher","first-page":"104037","DOI":"10.1016\/j.ebiom.2022.104037","volume":"80","author":"Z Luo","year":"2022","unstructured":"Luo Z, Health SL, Li M, Yang H, Wu Y, Collins M, Deeks SG, Martin JN, Scott A, Jiang W (2022) Variation in blood microbial lipopolysaccharide (LPS) contributes to immune reconstitution in response to suppressive antiretroviral therapy in HIV. EBioMedicine 80:104037. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104037","journal-title":"EBioMedicine"},{"issue":"2","key":"3343_CR26","first-page":"101","volume":"13","author":"RJ Henning","year":"2023","unstructured":"Henning RJ, Greene JN (2023) The epidemiology, mechanisms, diagnosis and treatment of cardiovascular disease in adult patients with HIV. Am J Cardiovasc Dis 13(2):101","journal-title":"Am J Cardiovasc Dis"},{"issue":"2","key":"3343_CR27","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1161\/ATVBAHA.122.318232","volume":"43","author":"MV Perkins","year":"2023","unstructured":"Perkins MV, Joseph SB, Dittmer DP, Mackman N (2023) Cardiovascular Disease and Thrombosis in HIV Infection. Arterioscler Thromb Vasc Biol 43(2):175\u2013191. https:\/\/doi.org\/10.1161\/ATVBAHA.122.318232","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"3343_CR28","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1093\/cid\/cis014","volume":"54","author":"PY Hsue","year":"2012","unstructured":"Hsue PY, Scherzer R, Grunfeld C, Nordstrom SM, Schnell A, Kohl LP, Nitta E, Martin JN, Deeks SG, Weiss EJ (2012) HIV infection is associated with decreased thrombin generation. Clin Infect Dis 54(8):1196\u20131203. https:\/\/doi.org\/10.1093\/cid\/cis014","journal-title":"Clin Infect Dis"},{"issue":"3","key":"3343_CR29","doi-asserted-by":"publisher","first-page":"590","DOI":"10.3390\/v14030590","volume":"14","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Peng F, Li M, Yi Q, Tang W, Wu S (2022) Elevated Risk of Venous Thromboembolism in People Living with HIV. Viruses 14(3):590. https:\/\/doi.org\/10.3390\/v14030590","journal-title":"Viruses"},{"issue":"6","key":"3343_CR30","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1182\/blood-2018-07-818211","volume":"133","author":"JP Luyendyk","year":"2019","unstructured":"Luyendyk JP, Schoenecker JG, Flick MJ (2019) The multifaceted role of fibrinogen in tissue injury and inflammation. Blood 133(6):511\u2013520. https:\/\/doi.org\/10.1182\/blood-2018-07-818211","journal-title":"Blood"},{"key":"3343_CR31","doi-asserted-by":"publisher","unstructured":"Reinhart WH (2003) Fibrinogen\u2013marker or mediator of vascular disease? Vasc Med. ;8(3):211\u2013216. https:\/\/doi.org\/10.1191\/1358863x03vm494ra. PMID: 14989564","DOI":"10.1191\/1358863x03vm494ra"},{"issue":"1","key":"3343_CR32","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.4102\/AJLM.v14i1.2756","volume":"14","author":"L Ndlovu","year":"2025","unstructured":"Ndlovu L, Thembane N, Jaya ZN (2025) Comparative analysis of inflammatory markers in HIV-positive individuals on antiretroviral therapy versus HIV-negative individuals in South Africa. Afr J Lab Med 14(1):2756","journal-title":"Afr J Lab Med"},{"issue":"4","key":"3343_CR33","first-page":"74","volume":"7","author":"OO Christine","year":"2020","unstructured":"Christine OO, Ifeanyichukwu Martin O, Kelechi NC, Oshim Ifeanyi O, Alfred EF, Emeka IP (2020) Some Inflammatory and Cardiovascular Marker Levels in Human Immuno\u2013Deficiency Virus Seropositive Individuals on Highly Active Antiretroviral Therapy with Hypertension in Nnewi. Eur J Biomedical 7(4):74\u201378","journal-title":"Eur J Biomedical"},{"issue":"1","key":"3343_CR34","first-page":"6782595","volume":"22","author":"S Getawa","year":"2022","unstructured":"Getawa S, Adane T (2022) Coagulation Parameters in Human Immunodeficiency Virus Infected Patients: A Systematic Review and Meta-Analysis. AIDS Res Treat 22(1):6782595","journal-title":"AIDS Res Treat"},{"issue":"1","key":"3343_CR35","first-page":"99","volume":"34","author":"FA Aisabokhale","year":"2019","unstructured":"Aisabokhale FA, Akingbola TS, Bamidele K (2019) D-dimer as a Predictor of Altered Coagulation in HIV Patients in Nigeria. Niger J Physiol Sci 34(1):99\u2013105","journal-title":"Niger J Physiol Sci"},{"issue":"1","key":"3343_CR36","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/COH.0000000000000019","volume":"9","author":"NT Funderburg","year":"2014","unstructured":"Funderburg NT (2014) Markers of coagulation and inflammation often remain elevated in ART-treated HIV-infected patients. Curr Opin HIV AIDS 9(1):80\u201386. https:\/\/doi.org\/10.1097\/COH.0000000000000019","journal-title":"Curr Opin HIV AIDS"},{"issue":"1","key":"3343_CR37","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1097\/QAI.0000000000002633","volume":"87","author":"WA van der Heijden","year":"2021","unstructured":"van der Heijden WA, Wan J, Van de Wijer L, Jaeger M, Netea MG, van der Ven AJ, de Mast Q (2021) Plasmatic coagulation capacity correlates with inflammation and abacavir use during chronic HIV infection. JAIDS J Acquir Immune Defic Syndr 87(1):711\u2013719","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"10","key":"3343_CR38","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1097\/QAD.0b013e32833ad914","volume":"24","author":"ES Ford","year":"2010","unstructured":"Ford ES, Greenwald JH, Richterman AG, Rupert A, Dutcher L, Badralmaa Y, Natarajan V, Rehm C, Hadigan C, Sereti I (2010) Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection. AIDS 24(10):1509\u20131517. https:\/\/doi.org\/10.1097\/QAD.0b013e32833ad914","journal-title":"AIDS"},{"issue":"6","key":"3343_CR39","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1097\/QAD.0b013e3282f560d9","volume":"22","author":"E Madden","year":"2008","unstructured":"Madden E, Lee G, Kotler DP, Wanke C, Lewis CE, Tracy R, Heymsfield S, Shlipak MG, Bacchetti P, Scherzer R, Grunfeld C (2008) Association of antiretroviral therapy with fibrinogen levels in HIV-infection. AIDS 22(6):707\u2013715. https:\/\/doi.org\/10.1097\/QAD.0b013e3282f560d9","journal-title":"AIDS"},{"issue":"3","key":"3343_CR40","doi-asserted-by":"publisher","first-page":"526","DOI":"10.21037\/cdt.2019.12.02","volume":"10","author":"AO Mocumbi","year":"2020","unstructured":"Mocumbi AO, Dobe I, C\u00e2ndido S, Kim N (2020) Cardiovascular risk and D-dimer levels in HIV-infected ART-na\u00efve Africans. Cardiovasc Diagn Ther 10(3):526\u2013533. https:\/\/doi.org\/10.21037\/cdt.2019.12.02","journal-title":"Cardiovasc Diagn Ther"},{"issue":"1","key":"3343_CR41","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/QAI.0b013e3181f7f61a","volume":"56","author":"JV Baker","year":"2011","unstructured":"Baker JV, Neuhaus J, Duprez D, Kuller LH, Tracy R, Belloso WH, De Wit S, Drummond F, Lane HC, Ledergerber B, Lundgren J, Nixon DE, Paton NI, Neaton JD, INSIGHT SMART Study Group (2011) Changes in inflammatory and coagulation biomarkers: a randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection. J Acquir Immune Defic Syndr 56(1):36\u201343. https:\/\/doi.org\/10.1097\/QAI.0b013e3181f7f61a","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"3343_CR42","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1186\/s12879-020-05213-1","volume":"20","author":"CA Teasdale","year":"2020","unstructured":"Teasdale CA, Hernandez C, Zerbe A, Chege D, Hawken M, El-Sadr WM (2020) Changes in D-dimer after initiation of antiretroviral therapy in adults living with HIV in Kenya. BMC Infect Dis 20(1):508","journal-title":"BMC Infect Dis"},{"issue":"4","key":"3343_CR43","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s11904-020-00509-y","volume":"17","author":"A Kettelhut","year":"2020","unstructured":"Kettelhut A, Bowman E, Funderburg NT (2020) Immunomodulatory and anti-inflammatory strategies to reduce comorbidity risk in people with HIV. Curr HIV\/AIDS Rep 17(4):394\u2013404","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"3","key":"3343_CR44","doi-asserted-by":"publisher","first-page":"e90978","DOI":"10.1371\/journal.pone.0090978","volume":"9","author":"AH Borges","year":"2014","unstructured":"Borges AH, O\u2019Connor JL, Phillips AN, Baker JV, Vjecha MJ, Losso MH, Klinker H, Lopardo G, Williams I, Lundgren JD, INSIGHT SMART Study Group; ESPRIT Study Group; SILCAAT Scientific Committee (2014) Factors associated with D-dimer levels in HIV-infected individuals. PLoS ONE 9(3):e90978. https:\/\/doi.org\/10.1371\/journal.pone.0090978","journal-title":"PLoS ONE"},{"issue":"5","key":"3343_CR45","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1007\/s13365-023-01145-z","volume":"29","author":"MA Hussain","year":"2023","unstructured":"Hussain MA, Watson CW, Morgan EE, Heaton RK, Letendre SL, Jeste DV, Moore DJ, Iudicello JE (2023) Combined effects of loneliness and inflammation on depression in people with HIV. J Neurovirol 29(5):538\u2013554","journal-title":"J Neurovirol"},{"key":"3343_CR46","doi-asserted-by":"publisher","first-page":"1930405","DOI":"10.1155\/2020\/1930405","volume":"2020","author":"C Lin","year":"2020","unstructured":"Lin C, Chen Y, Chen B, Zheng K, Luo X, Lin F (2020) D-Dimer Combined with Fibrinogen Predicts the Risk of Venous Thrombosis in Fracture Patients. Emerg Med Int 2020:1930405. https:\/\/doi.org\/10.1155\/2020\/1930405","journal-title":"Emerg Med Int"},{"issue":"6","key":"3343_CR47","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/j.1553-2712.2010.00765.x","volume":"17","author":"C Kabrhel","year":"2010","unstructured":"Kabrhel C, Mark Courtney D, Camargo CA Jr, Plewa MC, Nordenholz KE, Moore CL, Richman PB, Smithline HA, Beam DM, Kline JA (2010) Factors associated with positive D-dimer results in patients evaluated for pulmonary embolism. Acad Emerg Med 17(6):589\u2013597. https:\/\/doi.org\/10.1111\/j.1553-2712.2010.00765.x","journal-title":"Acad Emerg Med"},{"issue":"4","key":"3343_CR48","doi-asserted-by":"publisher","first-page":"e0214735","DOI":"10.1371\/journal.pone.0214735","volume":"14","author":"V Subramanya","year":"2019","unstructured":"Subramanya V, McKay HS, Brusca RM, Palella FJ, Kingsley LA, Witt MD, Hodis HN, Tracy RP, Post WS, Haberlen SA (2019) Inflammatory biomarkers and subclinical carotid atherosclerosis in HIV-infected and HIV-uninfected men in the Multicenter AIDS Cohort Study. PLoS ONE 14(4):e0214735","journal-title":"PLoS ONE"},{"issue":"13","key":"3343_CR49","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1161\/CIRCULATIONAHA.112.105908","volume":"126","author":"V Fuster","year":"2012","unstructured":"Fuster V, Bhatt DL, Califf RM, Michelson AD, Sabatine MS, Angiolillo DJ, Bates ER, Cohen DJ, Coller BS, Furie B, Hulot JS, Mann KG, Mega JL, Musunuru K, O\u2019Donnell CJ, Price MJ, Schneider DJ, Simon DI, Weitz JI, Williams MS, Hoots WK, Rosenberg YD, Hasan AA (2012) Guided antithrombotic therapy: current status and future research direction: report on a National Heart, Lung and Blood Institute working group. Circulation 126(13):1645\u20131662. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.105908","journal-title":"Circulation"},{"issue":"6","key":"3343_CR50","doi-asserted-by":"publisher","first-page":"564","DOI":"10.4161\/viru.25221","volume":"4","author":"SM Graham","year":"2013","unstructured":"Graham SM, Mwilu R, Liles WC (2013) Clinical utility of biomarkers of endothelial activation and coagulation for prognosis in HIV infection: a systematic review. Virulence 4(6):564\u2013571. https:\/\/doi.org\/10.4161\/viru.25221","journal-title":"Virulence"},{"issue":"1","key":"3343_CR51","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s40001-024-01750-6","volume":"29","author":"T Abadi","year":"2024","unstructured":"Abadi T, Teklu T, Wondmagegn T, Alem M, Desalegn G (2024) CD4\u2009+\u2009T cell count and HIV-1 viral load dynamics positively impacted by H. pylori infection in HIV-positive patients regardless of ART status in a high-burden setting. Eur J Med Res 29(1):178. https:\/\/doi.org\/10.1186\/s40001-024-01750-6","journal-title":"Eur J Med Res"},{"issue":"6","key":"3343_CR52","doi-asserted-by":"publisher","first-page":"e5950","DOI":"10.1371\/journal.pone.0005950","volume":"4","author":"EL Korenromp","year":"2009","unstructured":"Korenromp EL, Williams BG, Schmid GP, Dye C (2009) Clinical prognostic value of RNA viral load and CD4 cell counts during untreated HIV-1 infection\u2013a quantitative review. PLoS ONE 4(6):e5950. https:\/\/doi.org\/10.1371\/journal.pone.0005950","journal-title":"PLoS ONE"},{"issue":"7","key":"3343_CR53","doi-asserted-by":"publisher","first-page":"800","DOI":"10.3390\/biology14070800","volume":"14","author":"Y Chang","year":"2025","unstructured":"Chang Y, Lu J, Chen C (2025) Biomarkers in Venous Thrombosis: Diagnostic Potential and Limitations. Biology (Basel) 14(7):800. https:\/\/doi.org\/10.3390\/biology14070800","journal-title":"Biology (Basel)"},{"key":"3343_CR54","doi-asserted-by":"publisher","unstructured":"Wei M, Pan Y, Qin Z, Chen L, Zhao L, Zhong D (2025) Analysis of the diagnostic role of fibrin-related markers in perioperative venous thromboembolism. Front Surg 1530576. https:\/\/doi.org\/10.3389\/fsurg.2025.1530576","DOI":"10.3389\/fsurg.2025.1530576"},{"issue":"6","key":"3343_CR55","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1097\/COH.0b013e32833ed6f4","volume":"5","author":"DE Nixon","year":"2010","unstructured":"Nixon DE, Landay AL (2010) Biomarkers of immune dysfunction in HIV. Curr Opin HIV AIDS 5(6):498\u2013503. https:\/\/doi.org\/10.1097\/COH.0b013e32833ed6f4","journal-title":"Curr Opin HIV AIDS"},{"issue":"15","key":"3343_CR56","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1097\/QAD.0b013e3283489d1f","volume":"25","author":"SM Keating","year":"2011","unstructured":"Keating SM, Golub ET, Nowicki M, Young M, Anastos K, Crystal H, Cohen MH, Zhang J, Greenblatt RM, Desai S, Wu S, Landay AL, Gange SJ, Norris PJ (2011) Women\u2019s Interagency HIV Study. The effect of HIV infection and HAART on inflammatory biomarkers in a population-based cohort of women. AIDS 25(15):1823\u20131832. https:\/\/doi.org\/10.1097\/QAD.0b013e3283489d1f","journal-title":"AIDS"},{"issue":"1","key":"3343_CR57","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3390\/microorganisms11010221","volume":"11","author":"BM Nastri","year":"2023","unstructured":"Nastri BM, Pagliano P, Zannella C, Folliero V, Masullo A, Rinaldi L, Galdiero M, Franci G (2023) HIV and drug-resistant subtypes. Microorganisms 11(1):221","journal-title":"Microorganisms"},{"issue":"8","key":"3343_CR58","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.3390\/v15081732","volume":"15","author":"FE Foka","year":"2023","unstructured":"Foka FE, Mufhandu HT (2023) Current ARTs, virologic failure, and implications for AIDS management: a systematic review. Viruses 15(8):1732","journal-title":"Viruses"},{"issue":"4","key":"3343_CR59","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.immuni.2013.10.001","volume":"39","author":"SG Deeks","year":"2013","unstructured":"Deeks SG, Tracy R, Douek DC (2013) Systemic effects of inflammation on health during chronic HIV infection. Immunity 39(4):633\u2013645. https:\/\/doi.org\/10.1016\/j.immuni.2013.10.001","journal-title":"Immunity"},{"issue":"10","key":"3343_CR60","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.3390\/v14102287","volume":"14","author":"A Lembas","year":"2022","unstructured":"Lembas A, Za\u0142\u0119ski A, Miku\u0142a T, Dyda T, Sta\u0144czak W, Wierci\u0144ska-Drapa\u0142o A (2022) Evaluation of Clinical Biomarkers Related to CD4 Recovery in HIV-Infected Patients-5-Year Observation. Viruses 14(10):2287. https:\/\/doi.org\/10.3390\/v14102287","journal-title":"Viruses"},{"key":"3343_CR61","doi-asserted-by":"publisher","unstructured":"Oliveira R, Krauss M, Essama-Bibi S, Hofer C, Robert Harris D, Tiraboschi A, de Souza R, Marques H, Succi R, Abreu T, Della Negra M, Hazra R, Mofenson LM, Siberry GK, NISDI Pediatric Study Group (2010) Viral load predicts new world health organization stage 3 and 4 events in HIV-infected children receiving highly active antiretroviral therapy, independent of CD4 T lymphocyte value. Clin Infect Dis. 2010;51(11):1325\u20131333. https:\/\/doi.org\/10.1086\/657119","DOI":"10.1086\/657119"},{"issue":"6","key":"3343_CR62","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1097\/COH.0b013e32833ed7ec","volume":"5","author":"JV Baker","year":"2010","unstructured":"Baker JV, Duprez D (2010) Biomarkers and HIV-associated cardiovascular disease. Curr Opin HIV AIDS 5(6):511\u2013516. https:\/\/doi.org\/10.1097\/COH.0b013e32833ed7ec","journal-title":"Curr Opin HIV AIDS"},{"issue":"2","key":"3343_CR63","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3390\/biom16020235","volume":"16","author":"B Reardon","year":"2026","unstructured":"Reardon B, Pasalic L, Favaloro EJ (2026) Biomarkers of Coagulation Disorders-Where to from Here? Biomolecules 16(2):235. https:\/\/doi.org\/10.3390\/biom16020235","journal-title":"Biomolecules"},{"key":"3343_CR64","doi-asserted-by":"publisher","first-page":"670694","DOI":"10.3389\/fmed.2021.670694","volume":"8","author":"P Billoir","year":"2021","unstructured":"Billoir P, Alexandre K, Duflot T, Roger M, Miranda S, Goria O, Joly LM, Demeyere M, Feugray G, Brunel V, Etienne M (2021) Le Cam Duchez V. Investigation of Coagulation Biomarkers to Assess Clinical Deterioration in SARS-CoV-2 Infection. Front Med (Lausanne) 8:670694. https:\/\/doi.org\/10.3389\/fmed.2021.670694","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"3343_CR65","doi-asserted-by":"publisher","first-page":"e41222","DOI":"10.1097\/MD.0000000000041222","volume":"104","author":"EI Obeagu","year":"2025","unstructured":"Obeagu EI (2025) Influence of cytokines on the recovery trajectory of HIV patients on antiretroviral therapy: A review. Med (Baltim) 104(1):e41222. https:\/\/doi.org\/10.1097\/MD.0000000000041222","journal-title":"Med (Baltim)"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-026-03343-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-026-03343-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-026-03343-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T18:37:01Z","timestamp":1791743821000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-026-03343-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":65,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["3343"],"URL":"https:\/\/doi.org\/10.1007\/s11239-026-03343-y","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"18 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}